{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SMMT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T12:02:29.235Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8771,"canonical_name":"Summit Therapeutics Inc.","cik":"0001599298","uei":null,"lei":null,"duns":null,"ticker":"SMMT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":25},"count":25,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"4","title":"4 — Summit Therapeutics Inc. — 2026-10-14","url_slug":"/sec/cik-0001599298/4/0001890784-26-000006","accession_number":"0001890784-26-000006","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Summit Therapeutics Inc. — 2026-10-06","url_slug":"/sec/cik-0001599298/pre-14a/0001193125-26-415755","accession_number":"0001193125-26-415755","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-09-29","url_slug":"/sec/cik-0001599298/8-k/0001193125-26-405776","accession_number":"0001193125-26-405776","importance":35},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-09-15","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000081","accession_number":"0001599298-26-000081","importance":35},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-09-14","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000078","accession_number":"0001599298-26-000078","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-09-03","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000076","accession_number":"0001599298-26-000076","importance":35},{"ts":"2026-08-26","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-08-26","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000074","accession_number":"0001599298-26-000074","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-08-05","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000071","accession_number":"0001599298-26-000071","importance":35},{"ts":"2026-07-23","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Summit Therapeutics Inc. — 2026-07-23","url_slug":"/sec/cik-0001599298/10-q/0001599298-26-000068","accession_number":"0001599298-26-000068","importance":45},{"ts":"2026-07-23","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-07-23","url_slug":"/sec/cik-0001599298/8-k/0001193125-26-314214","accession_number":"0001193125-26-314214","importance":35},{"ts":"2026-07-23","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-07-23","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000067","accession_number":"0001599298-26-000067","importance":35},{"ts":"2026-07-23","kind":"sec.filing","form_type":"424B5","title":"424B5 — Summit Therapeutics Inc. — 2026-07-23","url_slug":"/sec/cik-0001599298/424b5/0001193125-26-314210","accession_number":"0001193125-26-314210","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-07-22","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000058","accession_number":"0001599298-26-000058","importance":35},{"ts":"2026-06-12","kind":"sec.insider.p","reporter":"DUGGAN ROBERT W","title":"Co-Chief Executive Officer","shares":3810000,"price_per_share":13.12,"usd_value":49987200,"security_title":"Common Stock","importance":90},{"ts":"2026-06-12","kind":"sec.insider.p","reporter":"Zanganeh Mahkam","title":"Co-Chief Executive Officer","shares":3810000,"price_per_share":13.12,"usd_value":49987200,"security_title":"Common Stock","importance":90},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-06-12","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000054","accession_number":"0001599298-26-000054","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Zanganeh Mahkam — 2026-06-12","url_slug":"/sec/cik-0001507650/4/0001507650-26-000007","accession_number":"0001507650-26-000007","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-06-11","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000052","accession_number":"0001599298-26-000052","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"424B5","title":"424B5 — Summit Therapeutics Inc. — 2026-06-10","url_slug":"/sec/cik-0001599298/424b5/0001193125-26-264471","accession_number":"0001193125-26-264471","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — Summit Therapeutics Inc. — 2026-06-09","url_slug":"/sec/cik-0001599298/s-3asr/0001193125-26-263861","accession_number":"0001193125-26-263861","importance":30},{"ts":"2026-06-04","kind":"sec.insider.p","reporter":"DUGGAN ROBERT W","title":"Co-Chief Executive Officer","shares":100000,"price_per_share":14.6,"usd_value":1460000,"security_title":"Common Stock","importance":51.46},{"ts":"2026-06-04","kind":"sec.insider.p","reporter":"Zanganeh Mahkam","title":"Co-Chief Executive Officer","shares":100000,"price_per_share":14.6,"usd_value":1460000,"security_title":"Common Stock","importance":51.46},{"ts":"2026-06-04","kind":"sec.insider.p","reporter":"Soni Manmeet Singh","title":"COO and CFO","shares":25000,"price_per_share":14.46,"usd_value":361500,"security_title":"Common Stock","importance":50.3615},{"ts":"2026-06-04","kind":"sec.insider.p","reporter":"Soni Manmeet Singh","title":"COO and CFO","shares":25000,"price_per_share":14.43,"usd_value":360750,"security_title":"Common Stock","importance":50.36075},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Summit Therapeutics Inc. — 2026-06-03","url_slug":"/sec/cik-0001599298/8-k/0001599298-26-000049","accession_number":"0001599298-26-000049","importance":35}]}